Since the initial discovery of this fusion, the YAP1–TFE3 fusion has also been identified in the clear-cell stromal tumor of the lung and in a case of cutaneous low-grade fibromyxoid neoplasm; no additional cancers have been identified that harbor the WWTR1–CAMTA1 fusion [62,63,64]. Here, CAMTA1 is linked to cancer.